Paper28024317
Induction of Nestin Early Expression as a Hallmark for Mesenchymal Stem Cells Expression of PDX-1 as a Pre-disposing Factor for Their Conversion into Insulin Producing Cells.
Martinez-Gamboa M and 3 others. Int J Stem Cells, 2017. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Induction of Nestin Early Expression as a Hallmark for Mesenchymal Stem Cells Expression of PDX-1 as a Pre-disposing Factor for Their Conversion into Insulin Producing Cells. Papers, record 28024317. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28024317
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Induction of Nestin Early Expression as a Hallmark for Mesenchymal Stem Cells Expression of PDX-1 as a Pre-disposing Factor for Their Conversion into Insulin Producing Cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15123649 | SREBP-1c mediates the insulin-dependent hepatic glucokinase expression. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15123649 | PubMed |
| 2 | 22974359 | Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. | Curr Diabetes Rev | 2013 | https://conductscience.org/library/papers/22974359 | PubMed |
| 3 | 25201603 | Improved differentiation of umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells by PDX-1 mRNA transfection. | Differentiation | 2014 | https://conductscience.org/library/papers/25201603 | PubMed |
| 4 | 15047618 | Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. | Diabetes | 2004 | https://conductscience.org/library/papers/15047618 | PubMed |
| 5 | 27143939 | Characterization of neural stemness status through the neurogenesis process for bone marrow mesenchymal stem cells. | Stem Cells Cloning | 2016 | https://conductscience.org/library/papers/27143939 | PubMed |
| 6 | 11326082 | Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. | Science | 2001 | https://conductscience.org/library/papers/11326082 | PubMed |
| 7 | 21160790 | Pancreatic islet transplantation. | World J Gastrointest Surg | 2009 | https://conductscience.org/library/papers/21160790 | PubMed |
| 8 | 23951327 | Insulin-producing cells derived from human embryonic stem cells: comparison of definitive endoderm- and nestin-positive progenitor-based differentiation strategies. | PLoS One | 2013 | https://conductscience.org/library/papers/23951327 | PubMed |
| 9 | 15378785 | Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. | World J Gastroenterol | 2004 | https://conductscience.org/library/papers/15378785 | PubMed |
| 10 | 11476858 | Type 1 diabetes: new perspectives on disease pathogenesis and treatment. | Lancet | 2001 | https://conductscience.org/library/papers/11476858 | PubMed |
| 11 | 22425523 | Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation. | J Biosci Bioeng | 2012 | https://conductscience.org/library/papers/22425523 | PubMed |
| 12 | 11508270 | Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000). Groupe de Recherche Rhin Rhĵne Alpes Genève pour la transplantation d'Ilots de Langerhans. | Diabetologia | 2001 | https://conductscience.org/library/papers/11508270 | PubMed |
| 13 | 17053790 | Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. | Nat Biotechnol | 2006 | https://conductscience.org/library/papers/17053790 | PubMed |
| 14 | 26576437 | Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus. | J Diabetes Res | 2015 | https://conductscience.org/library/papers/26576437 | PubMed |
| 15 | 17531117 | Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. | Chin Med J (Engl) | 2007 | https://conductscience.org/library/papers/17531117 | PubMed |
| 16 | 25287601 | Reprogramming human umbilical cord mesenchymal stromal cells to islet-like cells with the use of in vitro-synthesized pancreatic-duodenal homebox 1 messenger RNA. | Cytotherapy | 2014 | https://conductscience.org/library/papers/25287601 | PubMed |
| 17 | 23125199 | The pathogenesis and natural history of type 1 diabetes. | Cold Spring Harb Perspect Med | 2012 | https://conductscience.org/library/papers/23125199 | PubMed |
| 18 | 24275096 | Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors. | Int J Biochem Cell Biol | 2014 | https://conductscience.org/library/papers/24275096 | PubMed |
| 19 | 15464374 | Islet- and stem-cell-based tissue engineering in diabetes. | Curr Opin Biotechnol | 2004 | https://conductscience.org/library/papers/15464374 | PubMed |
| 20 | 22833839 | In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignant transformation. | Am J Stem Cells | 2012 | https://conductscience.org/library/papers/22833839 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32195201 | Differentiation Potential of Nestin (+) and Nestin (-) Cells Derived from Human Bone Marrow Mesenchymal Stem Cells into Functional Insulin Producing Cells. | Int J Mol Cell Med | 2019 | https://conductscience.org/library/papers/32195201 | PubMed |
| 30820250 | Stem cells as a potential therapy for diabetes mellitus: a call-to-action in Latin America. | Diabetol Metab Syndr | 2019 | https://conductscience.org/library/papers/30820250 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| PDX1 | 3651 | PubTator's text mining | https://conductscience.org/library/genes/3651 | NCBI Gene |
| SLC2A2 | 6514 | PubTator's text mining | https://conductscience.org/library/genes/6514 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28024317
GET https://conductscience.org/api/papers/v1/28024317/references?page=2